In this CME Outfitters live Q&A, expert faculty will answer questions about the multifaceted impact of GLP-1 RA therapies on glycemic control, CV health, weight management, renal health, liver health, and overall T2D complication risk.
0.5
11/13/2025 at 6:30 pm EST
Jay H. Shubrook, DO, FAAFP, FACOFP
Jay H. Shubrook, DO, FAAFP, FACOFP
Amy E. Rothberg, MD, DABOM
Amy E. Rothberg, MD, DABOM
Join our newsletter
Stay up to date on new CME Outfitters activities, breaking news, and important developments in medical education.
